SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Epic Sciences Awarded a Phase II SBIR Contract From National Cancer Institute/National Institutes of Health (NIH) to Develop a Lung Cancer Diagnostic Blood Test